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Examining Cancer-Related Pain and Quality of Life in Lehigh Valley Home Care Patients
L.G. Alley; H.D. Paxton; M.D. Flores; C. Foltz; J. Wike; V. Cunningham; J. Etchason
Lehigh Valley Health Network, Allentown, Pennsylvania

Introduction:
•D
 espite the availability of effective pain management measures in the United
States, cancer-related pain relief is frequently inadequate (NCCN, 2011; Stokowski,
2011; APS, 2008).
• The purpose of this descriptive pilot study is to characterize the status of pain
management for Lehigh Valley Health Network medical oncology patients who are
receiving home care services.    
• The study’s theoretical framework is an adaptation of Michael Harrison’s (1987)
model in which the healthcare organization is conceptualized as an open system
(Alley, 2001).

Study Objectives:
•T
 o describe the severity and nature of cancer-related pain experienced by Lehigh
Valley Home Care (LVHC) oncology patients and self-care measures they take to
relieve their pain.
• To examine relationships between selected pain and quality of life variables.
• To evaluate the feasibility and strengths/weaknesses of study protocols.
• To modify study materials for use in future, larger scale pain management projects.

Methods:
•D
 esign:  Descriptive, cross-sectional design, using a convenience sample of
LVHC cancer patients, to obtain quantitative data on subjects’ self-reports
about their pain, pain management, and perceived quality of life.
• Sample and Setting:  25 of 50 cancer patients enrolled thus far, receiving home
care services from LVHC.   
• Self-Report Measures:
− Cleeland’s Brief Pain Inventory (BPI)
− Ferrans and Powers Quality of Life Index (FP-QLI)
− European Organization into Research and Treatment of Cancer Quality of
Life Questionnaire (EORTC QLQ-C30)
− Investigator-developed 5-Day Pain Diary
• Procedure:  Study Interviewer conducts a one-hour structured in-home interview
with each subject.  Enrolled patients who agree also complete the 5-Day Pain
Diary.

Preliminary Results:
•2
 5 of 50 subjects have completed the study, to date.  Refer to Subject
Demographics in Table 1.

Table 1. Subject Demographics (n=25)
n

%

• B
 PI findings, particularly
Female
19
(76%)
noteworthy relative to the study’s
Age
64
(13)*
purpose and objectives:
Caucasian
23
(92%)
Education
• Of the 19 subjects reporting
     < High School
5
(20%)
having pain in the last week, 17
     High School Graduate
7
(28%)
(89%) rated their worst pain as >
     Some College or More
13
(52%)
5 (on a 0 to 10 scale), reflecting
Karnofsky Performance Status
76
(15)*
“substantial” pain intensity ratings
(as defined by Cleeland, Gonin,
* Mean and standard deviation.
Hatfield, Edmonson, Blum, Stewart,
& Pandya, 1994) that require focused healthcare provider interventions to reduce
pain ratings to more tolerable levels.  
• The mean pain intensity at its worst in the last week, reported by the 19 subjects,
was 6.9 (SD=1.8).
• All 19 subjects reporting pain had at least 1 active opioid prescription.  For the
remaining 6 subjects reporting no pain in the last week, most (n=4) had at least
one active opioid prescription.
• Tables 2 through 4 below present additional selected results from the BPI, as well
as selected results from the FP-QLI and the EORTC QLQ-C30, respectively.
Table 2. Brief Pain Inventory (BPI)
Only Subjects
with Pain in
Last Week
n=19
M

SD

Table 4. European Organization into Research
and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-C30) (n=25)

All Subjects
n=25
M

SD

Pain at its worst in the last
week

6.9

1.8

5.2

3.4

Pain at its least in the last
week

1.6

1.6

1.2

1.6

Mean pain interference
composite

3.3

2.7

2.5

2.8

All BPI pain ratings here range from 0-10, with higher ratings indicating higher
pain severity/intensity or more interference with seven daily activities (n=25).

Table 3. Ferrans and Powers Quality of Life Index
(FP-QLI) (n=25)
M

SD

Overall Quality of Life Score

21.3

5.2

Health & Functioning Subscale

17.5

7.3

Social & Economic Subscale

24.0

4.3

Psychological Spiritual Subscale

21.8

7.2

Family Subscale

26.1

4.1

Scores range from 0 – 30, with higher scores indicating better quality of life.

M

SD

58.3

26.1

Physical Functioning

66.5

24.9

Role Functioning

64.0

25.8

Emotional Functioning

74.3

26.5

Cognitive Functioning

79.3

20.6

Social Functioning

58.7

32.3

Fatigue Scale

47.6

24.7

Nausea/Vomiting Scale

0.0A

Pain Scale

32.7

29.8

Dyspnea Scale

22.7

28.4

Insomnia Scale

28.0

35.6

Appetite Loss Scale

37.3

35.1

Constipation Scale

22.7

32.9

Diarrhea Scale

0.0A

Financial Difficulties Scale

31.9

Global Health Status QoL+
Functioning Subscale+

Symptomatology Subscale@

39.9

+ Scores range from 0 – 100, with higher scores indicating better
QOL & functioning.
@
Scores range from 0 – 100, with higher scores indicating worse
symptomatology or problems.
A
Median value presented, given scores not normally distributed;
17/25 subjects reported no nausea/vomiting or diarrhea.

•A
 ll 21 subjects who agreed to use the 5-Day Pain Diary at home successfully
completed and returned it to the Study Interviewer.

Main Study Limitations:
•L
 VHN home care cancer patients experiencing the most severe pain may not be
well represented in the study sample.  Some home care patients have declined
study participation because they felt too ill and/or had a large amount of cancerrelated symptoms.
• Although the individual opioids prescribed are being documented for each subject
in the current study, the total amounts of opioids taken by subjects during the
completion of the 5-Day Pain Diary are not being recorded.  Thus, relationships
between opioids taken and pain intensity ratings cannot be examined in this
project.
• In most cases, a family member stayed in the room with subjects throughout
the assessment visits, which  may have prevented fully candid responses by
subjects. Given that these home visits were the first time that subjects had met the
Interviewer in person, the Interviewer did not ask famiy members to leave.
• To minimize the possibility of missing data, the Study Interviewer documents all
responses to the pain and quality of life instruments, using Teleform-formatted
paper data collection tools. Not having the instruments be self-administered by
subjects may affect some scores (as reported by the EORTC).

Initial Conclusions and Implications:
•D
 ata gathered thus far indicate that most subjects’ (17 of 19) worst pain reported
in the last week was “significant” (>5 on a 0-10 scale, as defined by Cleeland et
al., 1994), warranting increased attention and further interventions by healthcare
providers, to lower worst pain ratings to < 5.  Of the 19 patients reporting some
pain in the last week, all had at least one active opioid prescription.
• All subjects who agreed to complete the 5-Day Pain Diary (n=21) have done so
successfully, suggesting that the diary is not burdensome to home care patients
and that it may provide useful information to healthcare providers working to
relieve cancer patients’ pain.

